Nanosonics Ltd. (ASX: NAN) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Nanosonics Ltd. (ASX: NAN) Latest News
2 exciting ASX growth shares to buy for your portfolio
James Mickleboro | January 18, 2021 6:53am
How to turn $20,000 into $225,000 in 10 years with ASX shares
James Mickleboro | January 9, 2021 8:45am
Why a2 Milk, AVZ Minerals, Nanosonics, & Premier Investments are dropping lower
James Mickleboro | January 6, 2021 12:43pm
Are heads in the clouds with these sky high P/E ratios?
Mitchell Lawler | January 6, 2021 12:10pm
ASX 200 down 0.5%: Energy shares jump, big four banks fall, Zip climbs higher
James Mickleboro | January 6, 2021 12:03pm
Recent Stock Announcements
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Nanosonics Ltd. (ASX: NAN)
Nanosonics Ltd (NAN) was established in 2001 and is best known for its trophon® technology. The trophon device was launched in 2009 and pioneered a new standard for the disinfection of ultrasound probes. The technology is utilised to disinfect intracavity and surface ultrasound probes with the aim of significantly reducing the occurrence of cross contamination between patients.
Nanosonics listed on the ASX in 2007 and by 2015, its market capitalisation had grown so significantly it joined the ASX 300 Index. In just one more year, the continuing rise of the Nanosonics share price would see the company form part of the ASX 200 Index.
Headquartered in Sydney, Nanosonics employs over 200 people and has offices in the United States, Canada, the United Kingdom and Europe.
In 2018, the company launched trophon® 2, the latest innovation in its ultrasound disinfection technology. Nanasonics also manufactures and distributes a range of consumables and accessories that are used as part of the trophon system.
The company is committed to ongoing research and the continuing development of superior disinfection technologies.
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 88,659,425 | 29.49% |
| J P Morgan Nominees Australia Pty Limited | 43,213,979 | 14.37% |
| Citicorp Nominees Pty Limited | 15,863,058 | 5.28% |
| UBS Nominees Pty Ltd | 13,203,244 | 4.39% |
| Mr Bernard Stang | 8,692,111 | 2.89% |
| National Nominees Limited | 8,632,927 | 2.87% |
| Mr Maurie Stang | 8,629,534 | 2.87% |
| Mr Steve Kritzler | 8,489,737 | 2.82% |
| BNP Paribas Noms Pty Ltd <Drp> | 7,296,447 | 2.43% |
| BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> | 5,850,456 | 1.95% |
| Asia Union Investments Pty Limited | 2,500,000 | 0.83% |
| Dr Harry Hirschowitz | 2,139,090 | 0.71% |
| Avanteos Investments Limited <2349414 Hofbauer A/C> | 1,200,000 | 0.40% |
| Mr Michael Kavanagh | 1,018,363 | 0.34% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 925,122 | 0.31% |
| Powerwrap Limited <Scheme - Iml Trades A/C> | 903,206 | 0.30% |
| AMP Life Limited | 800,775 | 0.27% |
| Larinda Pty Ltd <Bg Superannuation Fund A/C> | 800,000 | 0.27% |
| Australian Foundation Investment Company Limited | 780,000 | 0.26% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 681,938 | 0.23% |